We only have this paper's title and publication details.
Read it at the sourceCaptured external expert commentary on this paper, strongest first. Original sources are linked where available.
“Taken together, the results from this analysis represent a key opportunity to intensify [cardiovascular] kidney therapies in real-world practice in high-risk CKD even without overt [cardiovascular disease] being present, given comparable event rates and benefits from therapies. Implementing thera...”
Journal, society, and media accounts. Useful signal, not independent expert judgment.
No takes yet. Share an insight, caveat, or question.
Rangaswami et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: